HFE Gene - Hereditary Hemochromatosis Protein

HFE Gene - Hereditary Hemochromatosis Protein

Introduction

The HFE gene encodes a protein involved in iron metabolism. Mutations in this gene cause hereditary hemochromatosis, a condition characterized by excessive iron accumulation in the body. Iron accumulation in the brain is increasingly recognized as a contributor to neurodegenerative diseases.

<div class="infobox infobox-gene">
<h3>HFE</h3>
<table>
<tr><th>Full Name</th><td>Homeostatic Iron Regulator</td></tr>
<tr><th>Chromosomal Location</th><td>6p22.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[3077](https://www.ncbi.nlm.nih.gov/gene/3077)</td></tr>
<tr><th>OMIM</th><td>[235200](https://www.omim.org/entry/235200)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000070010</td></tr>
<tr><th>UniProt</th><td>[Q30201](https://www.uniprot.org/uniprot/Q30201)</td></tr>
<tr><th>Associated Diseases</th><td>Hereditary Hemochromatosis, Alzheimer's Disease, Parkinson's Disease, Iron Accumulation Neurodegeneration</td></tr>
</table>
</div>

Overview

HFE Gene - Hereditary Hemochromatosis Protein

Introduction

The HFE gene encodes a protein involved in iron metabolism. Mutations in this gene cause hereditary hemochromatosis, a condition characterized by excessive iron accumulation in the body. Iron accumulation in the brain is increasingly recognized as a contributor to neurodegenerative diseases.

<div class="infobox infobox-gene">
<h3>HFE</h3>
<table>
<tr><th>Full Name</th><td>Homeostatic Iron Regulator</td></tr>
<tr><th>Chromosomal Location</th><td>6p22.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[3077](https://www.ncbi.nlm.nih.gov/gene/3077)</td></tr>
<tr><th>OMIM</th><td>[235200](https://www.omim.org/entry/235200)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000070010</td></tr>
<tr><th>UniProt</th><td>[Q30201](https://www.uniprot.org/uniprot/Q30201)</td></tr>
<tr><th>Associated Diseases</th><td>Hereditary Hemochromatosis, Alzheimer's Disease, Parkinson's Disease, Iron Accumulation Neurodegeneration</td></tr>
</table>
</div>

Overview

HFE (Homeostatic Iron Regulator), located on chromosome 6p22.2, encodes a membrane protein that plays a critical role in regulating iron absorption in the intestine["@references"]. Mutations in HFE cause hereditary hemochromatosis (HH), one of the most common genetic disorders in individuals of European ancestry, characterized by excessive iron absorption and accumulation in various organs including the liver, heart, pancreas, and brain["@ref1996"]. Recent research has highlighted connections between HFE variants and neurodegenerative diseases, where iron accumulation in specific brain regions contributes to oxidative stress and neuronal death["@ref2010"].

Function

The HFE gene encodes a 348-amino acid transmembrane protein that is structurally related to major histocompatibility complex (MHC) class I proteins:

• Iron sensing: HFE protein forms a complex with beta-2-microglobulin and interacts with transferrin receptor 1 (TfR1), modulating cellular iron uptake.
• Regulation of hepcidin: HFE regulates the expression of hepcidin, the key hormone controlling systemic iron homeostasis.
• Intestinal iron absorption: By modulating hepcidin, HFE controls iron absorption in the duodenum.
• Cellular iron metabolism: Influences intracellular iron levels through transferrin-mediated iron uptake.

Protein Structure

| Feature | Details |
|---------|---------|
| Molecular weight | ~40 kDa |
| Structure | MHC class I-like fold with alpha-1, alpha-2, alpha-3 domains |
| Transmembrane domain | Single pass at C-terminus |
| Binding | Binds beta-2-microglobulin; interacts with TfR1 |
| Post-translational modifications | N-glycosylation sites |

Disease Associations

Hereditary Hemochromatosis

• Inheritance: Autosomal recessive
• Prevalence: 1 in 200-400 individuals of European descent are homozygous for C282Y mutation.
• Symptoms: Fatigue, joint pain, bronze skin, diabetes, cardiomyopathy, liver cirrhosis.
• Penetrance: Variable; not all carriers develop clinical disease.
• Treatment: Phlebotomy, iron chelation therapy.

Neurodegeneration

Iron accumulation in the brain is a hallmark of several neurodegenerative diseases:

Alzheimer's Disease (AD)

• Evidence: Elevated iron levels found in AD brain, particularly in the [hippocampus](/brain-regions/hippocampus) and basal ganglia.
• Mechanism: Iron promotes [amyloid-beta](/proteins/amyloid-beta) aggregation and oxidative stress.
• HFE variants: C282Y heterozygotes may have increased AD risk[@ref2011].

Parkinson's Disease (PD)

• Evidence: Iron accumulation in substantia nigra of PD patients.
• Mechanism: Iron catalyzes oxidative damage to dopaminergic [neurons](/entities/neurons).
• HFE variants: Some studies suggest associations with earlier onset or severity[@ref2023].

Other Neurodegenerative Conditions

• Amyotrophic Lateral Sclerosis (ALS): Iron dysregulation observed in motor neurons.
• Multiple System Atrophy (MSA): Iron accumulation in putamen and cerebellum.
• Friedreich's Ataxia: Primary iron-sulfur cluster deficiency disease.
• Neurodegeneration with Brain Iron Accumulation (NBIA): Group of disorders characterized by iron accumulation.

Key Pathogenic Mutations

| Mutation | Effect | Frequency | Notes |
|----------|--------|-----------|-------|
| C282Y | Loss of function | Most common | H63D, S65C also risk factors |
| H63D | Mild dysfunction | Common | Usually benign; modifier effect |
| S65C | Mild dysfunction | Rare | Usually benign |

Expression

• High expression: Liver, small intestine, spleen, heart, brain.
• Cellular localization: Cell membrane, endosomal compartments.
• Regional specificity: Expressed in various brain regions including [cortex](/brain-regions/cortex), hippocampus, basal ganglia.
• Cell types: Enterocytes, hepatocytes, macrophages, neurons, [microglia](/cell-types/microglia-neuroinflammation).
• Regulation: Iron levels, inflammation, hepcidin.

Therapeutic Targeting

Iron Chelation

• Deferoxamine: FDA-approved chelator; may reduce brain iron in neurodegeneration.
• Deferasirox: Oral chelator; being studied for neuroprotection.
• Deferiprone: Crosses [blood-brain barrier](/entities/blood-brain-barrier); in trials for PD and AD.

Gene Therapy

• AAV-based HFE gene delivery under development.
• CRISPR approaches to correct HFE mutations.

Lifestyle Interventions

• Dietary iron reduction.
• Phlebotomy for HH patients (caution in neurodegeneration).

Animal Models

• Hfe knockout mice: Develop iron overload, useful for studying iron's role in neurodegeneration.
• Hfe x [APP](/entities/app-protein) double transgenic: Synergistic effects on amyloid pathology.
• Hfe x [alpha-synuclein](/proteins/alpha-synuclein) models: Investigate iron in synucleinopathies.

Key Publications

See Also

• [/diseases/hereditary-hemochromatosis](/diseases/hereditary-hemochromatosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [/mechanisms/iron-metabolism-neurodegeneration](/mechanisms/iron-metabolism-neurodegeneration)
• [/mechanisms/oxidative-stress-neurodegeneration](/mechanisms/oxidative-stress-neurodegeneration)

External Links

• [NCBI Gene: HFE](https://www.ncbi.nlm.nih.gov/gene/3077)
• [UniProt: Q30201](https://www.uniprot.org/uniprot/Q30201)
• [OMIM: 235200](https://www.omim.org/entry/235200)
• [American Hemochromatosis Society](https://www.americanhs.org/)
• [Iron Disorders Institute](https://www.irondisorders.org/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving HFE Gene - Hereditary Hemochromatosis Protein discovered through SciDEX knowledge graph analysis: